The investigators will study the effect of pulmonary arterial vasodilation to see if it
eliminates indices of persistent lung injury in smokers that are susceptible to emphysema.
Phase:
Phase 4
Details
Lead Sponsor:
Eric A. Hoffman
Collaborators:
National Heart, Lung, and Blood Institute (NHLBI) National Institutes of Health (NIH)